Evidence map›Paper›PMID 38224314›Full record

ArticleBiology of reproduction2024

Targeted deletion of NR2F2 and VCAM1 in theca cells impacts ovarian follicular development: insights into polycystic ovary syndrome?†.

Nicholes R Candelaria, JoAnne S Richards

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Biology of reproduction, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nicholes R CandelariaDepartment of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
JoAnne S RichardsDepartment of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Baylor College of Medicine · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Hashem B El-Serag · 2001 to 2026
$28.3M
Mechanisms Controlling Divergent Fates of Ovarian Follicles and FertilityR01HD076980 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 2014 to 2018
$1.9M
Novel Aspect of Androgen Action in Ovarian Cell Function and DysfunctionR01HD097321 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 2019 to 2023
$1.7M
NICHD NIH HHS R01 HD097321NIDDK NIH HHS P30 DK056338NIH HHS NIH-HD-076980
6 · The paper itself

Abstract

Defining features of polycystic ovary syndrome (PCOS) include elevated expression of steroidogenic genes, theca cell androgen biosynthesis, and peripheral levels of androgens. In previous studies, we identified vascular cell adhesion molecule 1 (VCAM1) as a selective androgen target gene in specific NR2F2/SF1 (+/+) theca cells. By deleting NR2F2 and VCAM1 selectively in CYP17A1 theca cells in mice, we documented that NR2F2 and VCAM1 impact distinct and sometimes opposing theca cell functions that alter ovarian follicular development in vivo: including major changes in ovarian morphology, steroidogenesis, gene expression profiles, immunolocalization images (NR5A1, CYP11A1, NOTCH1, CYP17A1, INSL3, VCAM1, NR2F2) as well as granulosa cell functions. We propose that theca cells impact follicle integrity by regulating androgen production and action, as well as granulosa cell differentiation/luteinization in response to androgens and gonadotropins that may underlie PCOS.

Indexed as

COUP Transcription Factor IIPolycystic Ovary SyndromeTheca CellsVascular Cell Adhesion Molecule-1AndrogensAnimalsFemaleGranulosa CellsMiceAndrogensCOUP Transcription Factor IINR2F2 protein, humanVascular Cell Adhesion Molecule-1CYP11A1CYP17A1NOTCH1NR2F2NR5A1PCOStheca cellsVCAM1

Identifiers

PMID38224314
PMCPMC11017119
OpenAlexW4390889692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.